Al-Massri, Khaled F <br/><br/>
Mesenchymal stem cells therapy enhances the efficacy of pregabalin and prevents its motor impairment in paclitaxel-induced neuropathy in rats: Role of Notch1 receptor and JAK/STAT signaling pathway.  [electronic resource] 

 -  Behavioural brain research  03 2019 
 - 303-311 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1872-7549 
<br/><br/><label>Standard No.: </label>10.1016/j.bbr.2018.12.013  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetone--toxicity<br/>Analysis of Variance<br/>Animals<br/>Antineoplastic Agents, Phytogenic--toxicity<br/>Antioxidants--metabolism<br/>Caspase 3--metabolism<br/>Cell- and Tissue-Based Therapy--methods<br/>Disease Models, Animal<br/>Hyperalgesia--physiopathology<br/>Interleukin-6--metabolism<br/>Janus Kinases--metabolism<br/>Male<br/>Mesenchymal Stem Cells--physiology<br/>Motor Disorders--etiology<br/>Nerve Growth Factor--metabolism<br/>Paclitaxel--toxicity<br/>Pregabalin--therapeutic use<br/>Rats<br/>Rats, Wistar<br/>Receptor, Notch1--metabolism<br/>Rotarod Performance Test<br/>STAT Transcription Factors--metabolism<br/>Sciatic Neuropathy--chemically induced<br/>Time Factors<br/>Tumor Necrosis Factor-alpha--metabolism